Published in PLoS One on August 21, 2012
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov Today (2013) 1.03
Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front Cell Infect Microbiol (2013) 1.03
Siderocalins: Siderophore binding proteins evolved for primary pathogen host defense. Curr Opin Chem Biol (2012) 0.92
Sodium/hydrogen exchanger NHA2 is critical for insulin secretion in β-cells. Proc Natl Acad Sci U S A (2013) 0.85
Purification and Structural Characterization of "Simple Catechol", the NGAL-Siderocalin Siderophore in Human Urine. RSC Adv (2015) 0.83
Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides. Proc Natl Acad Sci U S A (2015) 0.81
Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice. Mol Cell Biol (2014) 0.80
Coordination Chemistry of Microbial Iron Transport. Acc Chem Res (2015) 0.78
Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2) and the N-terminal Domain of Its Endocytic Receptor SLC22A17. J Biol Chem (2015) 0.77
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. Front Physiol (2016) 0.77
The bacteriostatic protein lipocalin 2 is induced in the central nervous system of mice with west Nile virus encephalitis. J Virol (2013) 0.76
Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine. J Biol Chem (2016) 0.76
The Ligands of Neutrophil Gelatinase-Associated Lipocalin. RSC Adv (2015) 0.76
CNS Anticancer Drug Discovery and Development Conference White Paper. Neuro Oncol (2015) 0.76
Iron depletion strategy for targeted cancer therapy: utilizing the dual roles of neutrophil gelatinase-associated lipocalin protein. J Mol Model (2016) 0.75
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol (1998) 14.18
SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics (1998) 11.91
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell (2002) 6.81
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A (1996) 5.53
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Iron-chelating therapy and the treatment of thalassemia. Blood (1997) 4.99
Improving biosensor analysis. J Mol Recognit (2000) 4.83
A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell (2005) 4.32
Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci U S A (2003) 3.94
Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2006) 3.85
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J (2004) 3.39
An iron delivery pathway mediated by a lipocalin. Mol Cell (2002) 3.38
Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science (2001) 3.03
Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. Talanta (1996) 2.74
Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure (2005) 2.63
The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A (2006) 2.63
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta (1997) 2.38
Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol (2010) 2.06
Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul (1997) 1.93
A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell (2010) 1.85
Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A (2006) 1.81
Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry (2000) 1.80
Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem (1990) 1.54
Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. Biochem Biophys Res Commun (1994) 1.54
Identification of alcaligin as the siderophore produced by Bordetella pertussis and B. bronchiseptica. J Bacteriol (1995) 1.45
Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem (1991) 1.42
The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport. J Am Chem Soc (2008) 1.19
The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms. Carcinogenesis (2011) 1.17
Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo. Carcinogenesis (2007) 1.14
The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta (1990) 1.11
Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase. J Biol Chem (2005) 1.11
Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition. J Am Chem Soc (2006) 1.08
The role of electrostatics in siderophore recognition by the immunoprotein Siderocalin. J Am Chem Soc (2008) 1.06
Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol Pharmacol (2009) 1.05
Lipocalin-2: pro- or anti-apoptotic? Cell Biol Toxicol (2009) 1.04
Domain preference in iron removal from human transferrin by the bacterial siderophores aerobactin and enterochelin. Eur J Biochem (1988) 0.99
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res (2011) 0.96
Mechanistic studies on trans-2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (Ent A) in the biosynthesis of the iron chelator enterobactin. Biochemistry (1990) 0.85
Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23. Mol Cell Biochem (2011) 0.83
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell (2002) 6.81
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56
An iron delivery pathway mediated by a lipocalin. Mol Cell (2002) 3.38
Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity (2005) 3.36
Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care (2007) 3.29
The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med (2011) 3.20
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol (2012) 2.97
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2004) 2.96
Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int (2011) 2.94
Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol (2004) 2.91
Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure (2005) 2.63
The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A (2006) 2.63
Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell (2009) 2.60
Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol (2006) 2.48
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci U S A (2006) 2.36
Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens (2006) 2.34
The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure (2010) 2.29
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature (2007) 2.26
Selective molecular recognition, C-H bond activation, and catalysis in nanoscale reaction vessels. Acc Chem Res (2005) 2.24
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest (2010) 2.23
The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev (2005) 2.22
"Cymothoe sangaris": an extremely stable and highly luminescent 1,2-hydroxypyridinonate chelate of Eu(III). J Am Chem Soc (2006) 2.21
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol (2006) 2.18
Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold. Science (2011) 2.17
Brilliant Sm, Eu, Tb, and Dy chiral lanthanide complexes with strong circularly polarized luminescence. J Am Chem Soc (2007) 2.14
Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway. J Immunol (2014) 2.11
Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A (2009) 2.08
Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol (2010) 2.06
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A (2010) 2.02
Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood (2004) 2.00
Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat Cell Biol (2002) 1.99
The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett (2005) 1.96
Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity. J Biol Inorg Chem (2005) 1.96
Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol (2009) 1.93
Rational design of sequestering agents for plutonium and other actinides. Chem Rev (2003) 1.92
Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure (2010) 1.91
Stable lanthanide luminescence agents highly emissive in aqueous solution: multidentate 2-hydroxyisophthalamide complexes of Sm(3+), Eu(3+), Tb(3+), Dy(3+). J Am Chem Soc (2003) 1.91
The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta (2002) 1.86
WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int (2008) 1.86
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. PLoS Pathog (2013) 1.85
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int (2008) 1.85
Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 1.81
Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure (2003) 1.81
Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A (2006) 1.81
From antenna to assay: lessons learned in lanthanide luminescence. Acc Chem Res (2009) 1.79
Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet (2009) 1.77
Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity (2003) 1.77
Cytotoxic T lymphocytes form an antigen-independent ring junction. J Clin Invest (2004) 1.72
Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. Inorg Chem (2003) 1.69
Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Inorg Chem (2004) 1.68
The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development (2010) 1.68
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood (2004) 1.67
Iron uptake and metabolism in the new millennium. Trends Cell Biol (2006) 1.66
High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. J Am Chem Soc (2008) 1.66
Acid catalysis in basic solution: a supramolecular host promotes orthoformate hydrolysis. Science (2007) 1.63
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew Chem Int Ed Engl (2008) 1.61
Enantiopure, octadentate ligands as sensitizers for europium and terbium circularly polarized luminescence in aqueous solution. J Am Chem Soc (2007) 1.60
Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat Genet (2009) 1.55
Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett (2007) 1.51
A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med (2007) 1.51
The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis (2006) 1.49
Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. Inorg Chem (2006) 1.49
N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion. PLoS One (2013) 1.46
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. J Med Chem (2009) 1.43
Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol (2003) 1.43
Highly luminescent lanthanide complexes of 1-hydroxy-2-pyridinones. Inorg Chem (2008) 1.43
Growth arrest and DNA damage-45 alpha (GADD45alpha). Int J Biochem Cell Biol (2008) 1.43
beta-catenin/TCF/Lef controls a differentiation-associated transcriptional program in renal epithelial progenitors. Development (2007) 1.42
Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem (2005) 1.41
The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol (2002) 1.40
Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res (2006) 1.39
Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol (2003) 1.38
Hexadentate hydroxypyridonate iron chelators based on TREN-Me-3,2-HOPO: variation of cap size. Inorg Chem (2002) 1.38
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem (2002) 1.38
The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem (2012) 1.38
Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem (2005) 1.36
Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents. Acc Chem Res (2009) 1.35
Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol (2009) 1.34
Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol (2005) 1.33